Nazmy, M., Abu-baih, D., El-Rehany, M., Fathy, M. (2021). Pathways of triple negative breast cancer. test, 32(4), 1-3. doi: 10.21608/mjmr.2021.241645
Maiiada Hassan Nazmy; Dalia Hamdy Abu-baih; Mahmoud Abdul-Aziz El-Rehany; Moustafa Fathy. "Pathways of triple negative breast cancer". test, 32, 4, 2021, 1-3. doi: 10.21608/mjmr.2021.241645
Nazmy, M., Abu-baih, D., El-Rehany, M., Fathy, M. (2021). 'Pathways of triple negative breast cancer', test, 32(4), pp. 1-3. doi: 10.21608/mjmr.2021.241645
Nazmy, M., Abu-baih, D., El-Rehany, M., Fathy, M. Pathways of triple negative breast cancer. test, 2021; 32(4): 1-3. doi: 10.21608/mjmr.2021.241645

Pathways of triple negative breast cancer

Minia Journal of Medical Research
Volume 32, Issue 4, October 2021, Pages 1-3    PDF (301.79 K)
Document Type: Review Article
DOI: 10.21608/mjmr.2021.241645
Authors
Maiiada Hassan Nazmy1; Dalia Hamdy Abu-baih2; Mahmoud Abdul-Aziz El-Rehany2; Moustafa Fathy3
1Department of Biochemistry, Faculty of Pharmacy, Minia University,
2Department of Biochemistry and molecular biology, Faculty of Pharmacy, Deraya University
3Department of Biochemistry, Faculty of Pharmacy, Minia University
Abstract
Breast malignances is among the most predominant malignancies in females worldwide. Annually, 
more than 1.5 million women (25 percent of all female cancer patients) are diagnosed with breast 
cancer each year. Sex, age, gene mutations, family history and an unhealthy lifestyle are among the 
risk factors which can raise the chance of breast cancer. Women are 100 times more likely than men 
to get breast cancer
Statistics
Article View: 176
PDF Download: 736